Junhui Sun

机构：Southwest University, Capital Medical University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Beijing Anzhen Hospital · ORCID：0000-0003-1947-8330

发表论文 101 篇 · 总被引 2618 次 · h-index 25

代表论文

• Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) (2022 · Journal of Clinical Oncology · 被引 453)
• Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) (2023 · Signal Transduction and Targeted Therapy · 被引 295)
• Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study (2023 · European Radiology · 被引 90)
• Development and validation of convolutional neural network-based model to predict the risk of sentinel or non-sentinel lymph node metastasis in patients with breast cancer: a machine learning study (2023 · EClinicalMedicine · 被引 58)
• Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations (2023 · Hepatology International · 被引 57)
• Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis (2023 · Journal of Nanobiotechnology · 被引 29)